India’s helpless position in vaccinating the country once again has come to the fore when it decided to add an item namely ‘discussion of Covid-19 vaccine supply to India’ in the agenda of the.
NEW DELHI: The Serum Institute has dissociated itself from its executive director’s statement that the government began the Covid-19 vaccination of multiple age groups without taking into consideration the available stock, stating that this is “not the view of the company”.
In a letter to the health ministry on May 22, Prakash Kumar Singh, director of government and regulatory affairs at the Pune-based Serum Institute of India (SII), clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company, sources said.
“On behalf of our CEO Adar C Poonawalla, I want to inform you that this statement is not issued on behalf of SIIPL (Serum Institute of India Pvt Ltd) and the company completely dissociates itself from this statement. this is not the view of the company at all.
Serum Institute disassociates itself from its executive s remarks on Covid vaccination drive
Prakash Kumar Singh, Director of Government and Regulatory Affairs at the SII clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company.
Share Via Email
| A+A A-
In this file photo, employees pack boxes containing vials of Covishield, a version of the AstraZeneca vaccine, at the Serum Institute of India in Pune | AP By PTI
NEW DELHI: The Serum Institute has disassociated itself from its executive director s statement that the government began the
COVID-19 vaccination of multiple age groups without taking into consideration the available stock, stating that this is not the view of the company .
The Serum Institute has disassociated itself from its executive director s statement that the government began the COVID-19 vaccination of multiple age groups without taking into consideration the available stock, stating that this is not the view of the company . In a letter to the Union Health Ministry on May 22, Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII), clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company, sources said. On behalf of our CEO Adar C Poonawalla, I want to inform you that this statement is not issued on behalf of SIIPL (Serum Institute of India Private Limited) and the Company completely dissociates itself from this statement. It is reiterated that, this is not the view of the company at all.